Innopharmax Inc.

  • Biotech or pharma, therapeutic R&D
  • Other R&D services

INNOPHARMAX is a clinical-stage pharmaceutical company (TPEx: 4172) focused on development and commercialization of ORAL new dosage form products. At BIO 2025, we focus on Assets for licensing and co-development in Oncology, Diabetes/Obesity, Hypertension, etc.

Address

Taipei
Taiwan

Website

http://www.innopharmax.com/

Contact Exhibitor


Loading
View all Partnering Companies

BIO DOUBLE HELIX SPONSORS

Our sponsors help support BIO's mission to support and advocate for the biotechnology industry.

BIO HELIX SPONSORS